Screening for cardiovascular disease marker in community health centers may reduce risk

New American Heart Association initiative, supported by Novartis Pharmaceuticals Corporation, aims to drive awareness, shared decision making around elevated lipoprotein(a), a genetic risk factor for cardiovascular disease